Skip to content

Hepatitis B treatment and care in the UK need to evolve to keep pace with the global epidemic

Any reduction in viral load has immunologic benefits for people with HIV who have triple-class treatment failure

Neurocognitive impairment results in poorer adherence to HIV therapy

Small UK study suggests that depression does not have an impact on hepatitis C treatment outcomes in people co-infected with HIV

US research shows that HPV vaccination could prevent pre-cancerous anal cell changes in HIV-positive gay men

Support improves hepatitis C treatment completion and response rates among drug users

Smoking has a bigger impact on the prognosis of HIV-positive patients than HIV-related factors

Aggressive therapy for MDR-TB reduces risk of disease recurrence

Poor CD4 response to HIV treatment increases risk of death from non-AIDS-related illnesses, even for those with higher baseline counts